GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)— 510(k) K250003

Substantially Equivalent

Geneseeq Technology, Inc.

FDA 510(k) clearance K250003 for GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005), Substantially Equivalent on 2025-08-29. Applicant: Geneseeq Technology, Inc..

Clearance details

Applicant: Geneseeq Technology, Inc.
Product code: Code PZM
Advisory panel: Pathology
Date received: 2025-01-02
Decision date: 2025-08-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Toronto, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.